ALR Technologies Inc.
ALR Technologies SG Ltd., a data management company, provides diabetes care management solutions for human and animal health diabetes. It offers ALRT Diabetes Solution, a diabetes care that includes a diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab report… Read more
ALR Technologies Inc. (ALRTF) - Net Assets
Latest net assets as of June 2024: $-34.09 Million USD
Based on the latest financial reports, ALR Technologies Inc. (ALRTF) has net assets worth $-34.09 Million USD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($45.84K) and total liabilities ($34.14 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-34.09 Million |
| % of Total Assets | -74372.74% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ALR Technologies Inc. - Net Assets Trend (2018–2023)
This chart illustrates how ALR Technologies Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ALR Technologies Inc. (2018–2023)
The table below shows the annual net assets of ALR Technologies Inc. from 2018 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-31.92 Million | -11.77% |
| 2022-12-31 | $-28.55 Million | -17.45% |
| 2021-12-31 | $-24.31 Million | -11.73% |
| 2020-12-31 | $-21.76 Million | +30.00% |
| 2019-12-31 | $-31.09 Million | -9.49% |
| 2018-12-31 | $-28.39 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ALR Technologies Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4145819200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $88.19 Million | % |
| Total Equity | $-31.92 Million | 100.00% |
ALR Technologies Inc. Competitors by Market Cap
The table below lists competitors of ALR Technologies Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Piedmont Lithium Inc
PINK:PLLTL
|
$1.38 Million |
|
Value Capital One Ltd
TA:PLTF
|
$1.38 Million |
|
Arcane Crypto AB
PINK:ARCNF
|
$1.38 Million |
|
Country Condo's Limited
NSE:COUNCODOS
|
$1.38 Million |
|
Greiffenberger AG
F:GRF
|
$1.38 Million |
|
Getaround Inc
OTCQB:GETR
|
$1.38 Million |
|
BOD Science Ltd
AU:BOD
|
$1.38 Million |
|
Martela Oyj A
HE:MARAS
|
$1.38 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ALR Technologies Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -28,554,785 to -31,916,155, a change of -3,361,370.
- Net loss of 7,474,514 reduced equity.
- New share issuances of 744,655 increased equity.
- Other factors increased equity by 3,368,489.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.47 Million | -23.42% |
| Share Issuances | $744.65K | +2.33% |
| Other Changes | $3.37 Million | +10.55% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares ALR Technologies Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $-0.12 | $0.01 | x |
| 2019-12-31 | $-0.12 | $0.01 | x |
| 2020-12-31 | $-0.04 | $0.01 | x |
| 2021-12-31 | $-0.04 | $0.01 | x |
| 2022-12-31 | $-0.05 | $0.01 | x |
| 2023-12-31 | $-0.05 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ALR Technologies Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -29270.50%
- • Asset Turnover: 0.16x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.28 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.90 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.74 Million |
| 2021 | 0.00% | -113059.92% | 0.04x | 0.00x | $-6.01 Million |
| 2022 | 0.00% | -448618.88% | 0.01x | 0.00x | $-7.76 Million |
| 2023 | 0.00% | -29270.50% | 0.16x | 0.00x | $-4.28 Million |
Industry Comparison
This section compares ALR Technologies Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ALR Technologies Inc. (ALRTF) | $-34.09 Million | 0.00% | N/A | $1.38 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |